537 related articles for article (PubMed ID: 28239942)
1. Extended treatment for cigarette smoking cessation: a randomized control trial.
Laude JR; Bailey SR; Crew E; Varady A; Lembke A; McFall D; Jeon A; Killen D; Killen JD; David SP
Addiction; 2017 Aug; 112(8):1451-1459. PubMed ID: 28239942
[TBL] [Abstract][Full Text] [Related]
2. A 12-week double-blind, placebo-controlled study of bupropion sr added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia.
Evins AE; Cather C; Culhane MA; Birnbaum A; Horowitz J; Hsieh E; Freudenreich O; Henderson DC; Schoenfeld DA; Rigotti NA; Goff DC
J Clin Psychopharmacol; 2007 Aug; 27(4):380-6. PubMed ID: 17632223
[TBL] [Abstract][Full Text] [Related]
3. Flexible, dual-form nicotine replacement therapy or varenicline in comparison with nicotine patch for smoking cessation: a randomized controlled trial.
Tulloch HE; Pipe AL; Els C; Clyde MJ; Reid RD
BMC Med; 2016 Jun; 14():80. PubMed ID: 27233840
[TBL] [Abstract][Full Text] [Related]
4. Extended cognitive behavior therapy for cigarette smoking cessation.
Killen JD; Fortmann SP; Schatzberg AF; Arredondo C; Murphy G; Hayward C; Celio M; Cromp D; Fong D; Pandurangi M
Addiction; 2008 Aug; 103(8):1381-90. PubMed ID: 18855829
[TBL] [Abstract][Full Text] [Related]
5. Extended treatment of older cigarette smokers.
Hall SM; Humfleet GL; Muñoz RF; Reus VI; Robbins JA; Prochaska JJ
Addiction; 2009 Jun; 104(6):1043-52. PubMed ID: 19392908
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial.
Jorenby DE; Hays JT; Rigotti NA; Azoulay S; Watsky EJ; Williams KE; Billing CB; Gong J; Reeves KR;
JAMA; 2006 Jul; 296(1):56-63. PubMed ID: 16820547
[TBL] [Abstract][Full Text] [Related]
7. Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial.
Gonzales D; Rennard SI; Nides M; Oncken C; Azoulay S; Billing CB; Watsky EJ; Gong J; Williams KE; Reeves KR;
JAMA; 2006 Jul; 296(1):47-55. PubMed ID: 16820546
[TBL] [Abstract][Full Text] [Related]
8. A controlled trial of bupropion added to nicotine patch and behavioral therapy for smoking cessation in adults with unipolar depressive disorders.
Evins AE; Culhane MA; Alpert JE; Pava J; Liese BS; Farabaugh A; Fava M
J Clin Psychopharmacol; 2008 Dec; 28(6):660-6. PubMed ID: 19011435
[TBL] [Abstract][Full Text] [Related]
9. Effects of Nicotine Patch vs Varenicline vs Combination Nicotine Replacement Therapy on Smoking Cessation at 26 Weeks: A Randomized Clinical Trial.
Baker TB; Piper ME; Stein JH; Smith SS; Bolt DM; Fraser DL; Fiore MC
JAMA; 2016 Jan; 315(4):371-9. PubMed ID: 26813210
[TBL] [Abstract][Full Text] [Related]
10. Assessment of Racial Differences in Pharmacotherapy Efficacy for Smoking Cessation: Secondary Analysis of the EAGLES Randomized Clinical Trial.
Nollen NL; Ahluwalia JS; Sanderson Cox L; Okuyemi K; Lawrence D; Samuels L; Benowitz NL
JAMA Netw Open; 2021 Jan; 4(1):e2032053. PubMed ID: 33464316
[TBL] [Abstract][Full Text] [Related]
11. Varenicline versus nicotine patch with brief advice for smokers with substance use disorders with or without depression: effects on smoking, substance use and depressive symptoms.
Rohsenow DJ; Tidey JW; Martin RA; Colby SM; Swift RM; Leggio L; Monti PM
Addiction; 2017 Oct; 112(10):1808-1820. PubMed ID: 28498504
[TBL] [Abstract][Full Text] [Related]
12. Combination Varenicline/Bupropion Treatment Benefits Highly Dependent Smokers in an Adaptive Smoking Cessation Paradigm.
Rose JE; Behm FM
Nicotine Tob Res; 2017 Aug; 19(8):999-1002. PubMed ID: 29054128
[TBL] [Abstract][Full Text] [Related]
13. An exploratory short-term double-blind randomized trial of varenicline versus nicotine patch for smoking cessation in women.
Gray KM; McClure EA; Baker NL; Hartwell KJ; Carpenter MJ; Saladin ME
Addiction; 2015 Jun; 110(6):1027-34. PubMed ID: 25727442
[TBL] [Abstract][Full Text] [Related]
14. Incremental efficacy of adding bupropion to the nicotine patch for smoking cessation in smokers with a recent history of alcohol dependence: results from a randomized, double-blind, placebo-controlled study.
Kalman D; Herz L; Monti P; Kahler CW; Mooney M; Rodrigues S; O'Connor K
Drug Alcohol Depend; 2011 Nov; 118(2-3):111-8. PubMed ID: 21507585
[TBL] [Abstract][Full Text] [Related]
15. Randomized trial of nicotine replacement therapy (NRT), bupropion and NRT plus bupropion for smoking cessation: effectiveness in clinical practice.
Stapleton J; West R; Hajek P; Wheeler J; Vangeli E; Abdi Z; O'Gara C; McRobbie H; Humphrey K; Ali R; Strang J; Sutherland G
Addiction; 2013 Dec; 108(12):2193-201. PubMed ID: 23859696
[TBL] [Abstract][Full Text] [Related]
16. Using extended cognitive behavioral treatment and medication to treat dependent smokers.
Hall SM; Humfleet GL; Muñoz RF; Reus VI; Prochaska JJ; Robbins JA
Am J Public Health; 2011 Dec; 101(12):2349-56. PubMed ID: 21653904
[TBL] [Abstract][Full Text] [Related]
17. Effects of Combined Varenicline With Nicotine Patch and of Extended Treatment Duration on Smoking Cessation: A Randomized Clinical Trial.
Baker TB; Piper ME; Smith SS; Bolt DM; Stein JH; Fiore MC
JAMA; 2021 Oct; 326(15):1485-1493. PubMed ID: 34665204
[TBL] [Abstract][Full Text] [Related]
18. Outcomes from an outpatient smoking-cessation clinic.
Roth MT; Andrus MR; Westman EC
Pharmacotherapy; 2005 Feb; 25(2):279-88. PubMed ID: 15767242
[TBL] [Abstract][Full Text] [Related]
19. Smoking Cessation Treatment for Patients With Mental Disorders Using CBT and Combined Pharmacotherapy.
Loreto AR; Carvalho CFC; Frallonardo FP; Ismael F; Andrade AG; Castaldelli-Maia JM
J Dual Diagn; 2017; 13(4):238-246. PubMed ID: 28489501
[TBL] [Abstract][Full Text] [Related]
20. An exploratory randomized controlled trial of a novel high-school-based smoking cessation intervention for adolescent smokers using abstinence-contingent incentives and cognitive behavioral therapy.
Krishnan-Sarin S; Cavallo DA; Cooney JL; Schepis TS; Kong G; Liss TB; Liss AK; McMahon TJ; Nich C; Babuscio T; Rounsaville BJ; Carroll KM
Drug Alcohol Depend; 2013 Sep; 132(1-2):346-51. PubMed ID: 23523130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
